<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Aprea Therapeutics, Inc. (APRE) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/apre/filings</link>
    <description>Latest company filings for Aprea Therapeutics, Inc. (APRE) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sun, 12 Jul 2026 23:11:44 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/apre/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[APRE: 424B7]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926062631/tm2614801d1_424b7.htm</link>
      <guid isPermaLink="false">0001104659-26-062631</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a 424B7 (424B7) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>424B7</category>
    </item>
    <item>
      <title><![CDATA[APRE: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000090266426002544/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-002544</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[APRE: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926059743/apre-20260331x10q.htm</link>
      <guid isPermaLink="false">0001104659-26-059743</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926059734/apre-20260513x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-059734</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926052063/apre-20251231xars.pdf</link>
      <guid isPermaLink="false">0001104659-26-052063</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[APRE: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926052049/apre-20260430xdefa14a.htm</link>
      <guid isPermaLink="false">0001104659-26-052049</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[APRE: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926052044/apre-20260616xdef14a.htm</link>
      <guid isPermaLink="false">0001104659-26-052044</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[APRE: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/999999999526001389/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-001389</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a EFFECT (EFFECT) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[APRE: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926051739/tm2612147-4_424b3.htm</link>
      <guid isPermaLink="false">0001104659-26-051739</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a 424B3 (424B3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[APRE: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000149315226019073/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001493152-26-019073</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[APRE: Company correspondence (CORRESP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926049298/filename1.htm</link>
      <guid isPermaLink="false">0001104659-26-049298</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Company correspondence (CORRESP) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>CORRESP</category>
    </item>
    <item>
      <title><![CDATA[APRE: SEC correspondence (UPLOAD)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000000000026004268/filename1.pdf</link>
      <guid isPermaLink="false">0000000000-26-004268</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SEC correspondence (UPLOAD) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>UPLOAD</category>
    </item>
    <item>
      <title><![CDATA[APRE: Securities registration (S-3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926046900/tm2612147-1_s3.htm</link>
      <guid isPermaLink="false">0001104659-26-046900</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Securities registration (S-3) on 2026-04-22.]]></description>
      <pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
      <category>S-3</category>
    </item>
    <item>
      <title><![CDATA[APRE: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926045158/apre-20260616xpre14a.htm</link>
      <guid isPermaLink="false">0001104659-26-045158</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a PRE 14A (PRE 14A) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[APRE: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000205070926000012/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0002050709-26-000012</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-07.]]></description>
      <pubDate>Tue, 07 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[APRE: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000121390026038610/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001213900-26-038610</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926038522/xslF345X06/tm2610878-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-038522</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926038518/xslF345X06/tm2610878-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-038518</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926038258/apre-20260401x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-038258</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926036821/tm2610566d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-26-036821</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-30.]]></description>
      <pubDate>Mon, 30 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/999999999526000871/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-000871</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a EFFECT (EFFECT) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[APRE: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926032181/tm269283-1_424b3.htm</link>
      <guid isPermaLink="false">0001104659-26-032181</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a 424B3 (424B3) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[APRE: S-3/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926029519/tm268966d1_s3a.htm</link>
      <guid isPermaLink="false">0001104659-26-029519</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a S-3/A (S-3/A) on 2026-03-17.]]></description>
      <pubDate>Tue, 17 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-3/A</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926028656/xslF345X05/tm268953-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-028656</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926028653/xslF345X05/tm268953-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-028653</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926028509/tm268514d1_s8.htm</link>
      <guid isPermaLink="false">0001104659-26-028509</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[APRE: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926028068/apre-20251231x10k.htm</link>
      <guid isPermaLink="false">0001104659-26-028068</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Annual report (10-K) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926028046/apre-20260316x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-028046</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: Securities registration (S-3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926017755/tm266572-1_s3.htm</link>
      <guid isPermaLink="false">0001104659-26-017755</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Securities registration (S-3) on 2026-02-20.]]></description>
      <pubDate>Fri, 20 Feb 2026 12:00:00 GMT</pubDate>
      <category>S-3</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926016797/tm266669d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-26-016797</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926015324/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-015324</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-13.]]></description>
      <pubDate>Fri, 13 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926009206/xslF345X05/tm264801-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-009206</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926009203/xslF345X05/tm264801-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-009203</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926007988/tm264417d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-26-007988</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-29.]]></description>
      <pubDate>Thu, 29 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000149315226003971/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001493152-26-003971</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-01-28.]]></description>
      <pubDate>Wed, 28 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926006267/tm263963d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-26-006267</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-23.]]></description>
      <pubDate>Fri, 23 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465926002490/apre-20260109x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-002490</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925124943/tm2533811-4_424b3.htm</link>
      <guid isPermaLink="false">0001104659-25-124943</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a 424B3 (424B3) on 2025-12-30.]]></description>
      <pubDate>Tue, 30 Dec 2025 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[APRE: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/999999999525003942/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-25-003942</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a EFFECT (EFFECT) on 2025-12-29.]]></description>
      <pubDate>Mon, 29 Dec 2025 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[APRE: D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000178198325000003/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001781983-25-000003</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a D (D) on 2025-12-29.]]></description>
      <pubDate>Mon, 29 Dec 2025 12:00:00 GMT</pubDate>
      <category>D</category>
    </item>
    <item>
      <title><![CDATA[APRE: Securities registration (S-3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925123130/tm2533811-1_s3.htm</link>
      <guid isPermaLink="false">0001104659-25-123130</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Securities registration (S-3) on 2025-12-19.]]></description>
      <pubDate>Fri, 19 Dec 2025 12:00:00 GMT</pubDate>
      <category>S-3</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925120156/xslF345X05/tm2533219-3_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-120156</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2025-12-11.]]></description>
      <pubDate>Thu, 11 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925120155/xslF345X05/tm2533219-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-120155</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2025-12-11.]]></description>
      <pubDate>Thu, 11 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925120152/xslF345X05/tm2533219-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-120152</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Insider trade (4) on 2025-12-11.]]></description>
      <pubDate>Thu, 11 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925119680/tm2533057d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-25-119680</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2025-12-09.]]></description>
      <pubDate>Tue, 09 Dec 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[APRE: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925119074/tm2532817d1_s8.htm</link>
      <guid isPermaLink="false">0001104659-25-119074</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Employee stock plan (S-8) on 2025-12-08.]]></description>
      <pubDate>Mon, 08 Dec 2025 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[APRE: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000093583625000708/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000935836-25-000708</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[APRE: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000121465925016261/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001214659-25-016261</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-11-12.]]></description>
      <pubDate>Wed, 12 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[APRE: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925109867/apre-20250930x10q.htm</link>
      <guid isPermaLink="false">0001104659-25-109867</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Quarterly report (10-Q) on 2025-11-12.]]></description>
      <pubDate>Wed, 12 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[APRE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781983/000110465925109860/apre-20251112x8k.htm</link>
      <guid isPermaLink="false">0001104659-25-109860</guid>
      <description><![CDATA[Aprea Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-12.]]></description>
      <pubDate>Wed, 12 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
  </channel>
</rss>